Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker

被引:12
|
作者
Sikka, K. [1 ]
Sharma, S. C. [1 ]
Thakar, A. [1 ]
Dattagupta, S. [2 ]
机构
[1] All India Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 2012年 / 126卷 / 05期
关键词
Cholesteatoma; Child; Cellular Proliferation; Pathology; MIDDLE-EAR CHOLESTEATOMA; NUCLEAR ANTIGEN; MEATAL SKIN; CELL; QUANTIFICATION; CHILDREN; MIB-1;
D O I
10.1017/S002221511100315X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The aggressiveness of cholesteatoma in children compared with adults is well known. However, the factors influencing the poorer prognosis of paediatric cholesteatoma are not well understood. This study compared the proliferative potential of paediatric cholesteatoma with that of adult cholesteatoma, using Ki-67 as a proliferation marker. Methods: A prospective study of 67 patients with aural cholesteatoma was performed. Thirty-eight adult and 29 paediatric cases were evaluated using clinical parameters including bone erosion, complications and extent of disease. A surgical specimen underwent histological evaluation and measurement of the proliferation index using Ki-67 labelling. Normal epithelium from a control group was also examined. Results: Cholesteatoma epithelium has a greater rate of proliferation than normal skin. There were however no statistical differences between the paediatric and adult cholesteatoma groups in terms of clinical behaviour or proliferation potential. Paediatric cholesteatoma was similar to adult cholesteatoma in terms of complications, bone erosion and disease spread. Conclusion: Cholesteatoma is a disorder of epithelial proliferation. Although postulated to be more aggressive in children than adults, this study found no clinicopathological differences between paediatric and adult cases.
引用
收藏
页码:460 / 463
页数:4
相关论文
共 50 条
  • [21] Expression of the proliferation marker Ki-67 during early mouse development
    Winking, H
    Gerdes, J
    Traut, W
    CYTOGENETIC AND GENOME RESEARCH, 2004, 105 (2-4) : 251 - 256
  • [22] The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma
    Mirian, Christian
    Skyrman, Simon
    Bartek, Jiri
    Jensen, Lasse Rehne
    Kihlstrom, Lars
    Forander, Petter
    Orrego, Abiel
    Mathiesen, Tiit
    NEUROSURGERY, 2021, 89 : S58 - S58
  • [23] Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes
    Khanna, Omaditya
    Kazerooni, Anahita Fathi
    Arif, Sherjeel
    Mahtabfar, Aria
    Momin, Arbaz A.
    Andrews, Carrie E.
    Hafazalla, Karim
    Baldassari, Michael P.
    Velagapudi, Lohit
    Garcia, Jose A.
    Sako, Chiharu
    Farrell, Christopher J.
    Evans, James J.
    Judy, Kevin D.
    Andrews, David W.
    Flanders, Adam E.
    Shi, Wenyin
    Davatzikos, Christos
    NEUROSURGICAL FOCUS, 2023, 54 (06)
  • [24] Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma
    Dono, Antonio
    Chandra, Ankush
    Ballester, Leomar Y.
    Esquenazi, Yoshua
    NEUROSURGERY, 2021, 89 (01) : E66 - E67
  • [25] Usefulness of Ki-67 proliferation marker in the cytologic identification of liver tumors in dogs
    Neumann, S
    Kaup, FJ
    VETERINARY CLINICAL PATHOLOGY, 2005, 34 (02) : 132 - 136
  • [26] Ki-67 Proliferation Rate as a Prognostic Marker in Major Salivary Gland Carcinomas
    Vacchi-Suzzi, Martino
    Bocciolini, Corso
    Bertarelli, Claudia
    Dall'Olio, Danilo
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2010, 119 (10): : 677 - 683
  • [27] The Predictive Value of the Proliferation Marker Ki-67 in Patients With Fulminant Hepatic Failure
    Shah, A.
    Joneja, U.
    Walls, D.
    Farber, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [28] Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.
    Hoster, Eva
    Klapper, Wolfram
    Rosenwald, Andreas
    Bernd, Heinz-Wolfram
    Hartmann, Sylvia
    Loddenkemper, Christoph
    Barth, Thomas F. E.
    Hiddemann, Wolfgang
    Unterhalt, Michael
    Kluin-Nelemans, Hanneke C.
    Hermine, Olivier
    Dreyling, Martin
    BLOOD, 2012, 120 (21)
  • [29] The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours
    Foltyn, Wanda
    Zajecki, Wojciech
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Sieminska, Lucyna
    Zemczak, Anna
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2012, 63 (05) : 362 - 366
  • [30] Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma
    Wong, Eugene
    Nahar, Najmun
    Hau, Eric
    Varikatt, Winny
    Gebski, Val
    Ng, Thomas
    Jayamohan, Jayasingham
    Sundaresan, Puma
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (01) : 5 - 9